Skip to main content
  • Capability

FDA ASCA Pilot Program

FDA ASCA-accredited testing services from UL help to increase confidence in premarket medical device testing.

scientist adding fluid test tube

Build confidence in premarket medical device reviews

The U.S. Food and Drug Administration (FDA) voluntary Accreditation Scheme for Conformity Assessment (ASCA) Pilot program is designed to improve the premarket review process. It was created to increase FDA product reviewers’ and device manufacturers’ confidence in medical device testing when performed by an ASCA-accredited laboratory and should help reduce the need for additional testing or information during the premarket review process.

As of April 2021, UL is an FDA ASCA-accredited testing laboratory. Our healthcare experts have a deep understanding of the industry and offer comprehensive testing and certification services throughout the entire production life cycle. With testing services conducted in one of nine laboratories across the U.S., Europe and Asia, we can help you take advantage of this program and build confidence in the process. When using UL to perform testing, you can reference this testing in your declaration of conformity (DOC) and provide all necessary supplemental information.

Working with UL can help:

  • Reduce the number of FDA requests related to testing
  • Reduce the need for repeat or revised testing
  • Potentially save time and money spent on retesting with limited documentation requirements
  • Provide flexibility and consistency in the premarket review process, ranging from a single test to certifications depending on your needs
  • Assist medical device manufacturers in meeting the FDA's regulatory requirements
  • Increase your confidence with testing

Additionally, many of the FDA-recognized consensus standards and test methods included in the ASCA Pilot are based on international consensus standards. As a result, UL’s FDA ASCA scope of accreditation covers the majority of the global standards and helps support international harmonization.

Here are the two primary standards covering basic safety and essential performance that are included in the FDA ASCA Pilot:

STANDARD DESCRIPTION
ANSI/AAMI 60601-1 Medical electrical equipment – Part 1: General requirements for basic safety and essential performance (Including the FDA-recognized list of collateral and particular standards of the IEC/ISO 60601/80601 series of medical standards)
IEC 61010-1 Safety requirements for electrical equipment for measurement, control, and laboratory use – Part 1: General requirements (along with the FDA-recognized particular standards of the IEC 61010 series of laboratory standards family)

 

Our FDA ASCA laboratory offerings

Region Americas Europe Asia
Locations
  • Brea, California
  • Fremont, California
  • Mounds View, Minnesota
  • Northbrook, Illinois
  • Melville, New York
  • Research Triangle Park, North Carolina
  • Neu Isenburg, Germany
  • Warsaw, Poland
  • Ise-Shi Mie-Ken, Japan
  • Guangzhou, China
  • Suzhou, China
  • Taiwan, China
Specialties
  • Patient monitoring
  • Imaging
  • Applied energy
  • Patient monitoring
  • Imaging
  • Patient monitoring
  • Imaging
  • Applied energy
Collaterals
  • X-ray
  • Alarms
  • Home use
  • Emergency medical
  • X-ray
  • Alarms
  • Home use
  • Emergency medical
  • X-ray
  • Alarms
  • Home use
EMC
  • Fremont, California
  • Northbrook, Illinois
  • Research Triangle Park, North Carolina
 
  • Guangzhou, China
  • Taiwan, China

View our accreditation scope for the ASCA Pilot program.

Lab worker testing product

Introduction to the US FDA’s ASCA Pilot Program

Learn about the new Accreditation Scheme for Conformity Assessment Pilot program and its effect on medical device testing.

Learn more

Get in touch

Have questions, need specifics? Let's get this conversation started.

Help and support

How can we help?